LCM
AGIO icon

Landscape Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Landscape Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,123
Closed -$436K – 576
2019
Q4 		$436K Buy
+9,123
New +$345K 0.03% 469
2019
Q2 		– Sell
-3,453
Closed -$233K – 634
2019
Q1 		$233K Buy
+3,453
New +$201K 0.02% 587
2016
Q1 		– Sell
-12,752
Closed -$828K – 558
2015
Q4 		$828K Buy
+12,752
New +$836K 0.1% 259

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Landscape Capital Management's AGIO Position: Q1 2020 in Review

Landscape Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2020, closing a stake of 9,123 shares — an estimated $436K sold.

Landscape Capital Management first reported a position in AGIO in Q4 2015 and held it in 3 quarters. The position peaked at $828K in Q4 2015. 197 funds tracked by Wall St. Rank hold AGIO as of Q1 2020.

  • Landscape Capital Management reported no remaining Agios Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Landscape Capital Management sold 9,123 Agios Pharmaceuticals shares in Q1 2020, an estimated $436K.
  • Landscape Capital Management first reported a position in Agios Pharmaceuticals in Q4 2015 and held it in 3 quarters.
  • Landscape Capital Management's Agios Pharmaceuticals position peaked at $828K in Q4 2015.
  • 197 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2020.

Based on Landscape Capital Management's 13F filing for Q1 2020, filed 13 May 2020.